The Regulation of Clinical Stem Cell Research and Applications: three dynamics of global regulatory diversification (part 1)
In the first part of this commentary, Achim Rosemann introduces the regulatory landscape of clinical stem cell research and describes the emerging of a growing number of regulatory exceptions and exemptions.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.